share_log

Ocugen Announces Preliminary Data For OCU410l; Findings Included No Drug-related Serious Adverse Events, Reduced Lesion Growth, Preservation Of Retinal Tissue, Positive Effect On The Functional Visual Measure Of Low Luminance Visual Acuity

Ocugen Announces Preliminary Data For OCU410l; Findings Included No Drug-related Serious Adverse Events, Reduced Lesion Growth, Preservation Of Retinal Tissue, Positive Effect On The Functional Visual Measure Of Low Luminance Visual Acuity

Ocugen宣布OCU410l的初步数据;研究结果包括没有药物相关的严重不良事件,减少病变生长,保留视网膜组织,对低照度视力的功能视觉测量产生积极影响。
Benzinga ·  11/19 07:08

Ocugen Announces Preliminary Data For OCU410l; Findings Included No Drug-related Serious Adverse Events, Reduced Lesion Growth, Preservation Of Retinal Tissue, Positive Effect On The Functional Visual Measure Of Low Luminance Visual Acuity

ocugen 发布 OCU410l 的初步数据;结果包括没有与药物相关的严重不良事件,病变生长减缓,视网膜组织保存,对低亮度视觉敏感度的功能视觉测量产生积极影响。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发